Stay updated on Immunotherapy for Bladder Cancer Patients Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy for Bladder Cancer Patients Clinical Trial page.

Latest updates to the Immunotherapy for Bladder Cancer Patients Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe webpage has updated the details of a pilot study evaluating neoadjuvant nivolumab and ipilimumab for muscle-invasive bladder cancer, including a change in the principal investigator from Gopakumar Iyer, MD to Scott Niglio, MD, and the addition of new study dates.SummaryDifference43%
- Check43 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check51 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check87 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check101 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Immunotherapy for Bladder Cancer Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Bladder Cancer Patients Clinical Trial page.